Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Journal of Comparative Effectiveness Research|February 9, 2017
Patient, caregiver and clinician use of comparative effectiveness research findings in care decisions: results from a national studyLori B Frank, Laura P Forsythe, Thomas A Workman, et al.
Journal of Comparative Effectiveness Research|February 9, 2017
Health researcher views on comparative effectiveness research and research engagementLaura P Forsythe, Lori B Frank, Thomas A Workman, et al.
AIDS (London, England)|August 13, 2002
Minimal variation in T-20 binding domain of different HIV-1 subtypes from antiretroviral-naive and -experienced patientsLi Xu, Stéphane Hué, Stephen Taylor, et al.
International Journal of Surgical Pathology|February 15, 2024
Chondrolipoma of the Breast: A Myofibroblastoma Variant or a Distinct Lesion?Adrienne A Workman, Donald C Green, Edward G Hughes, et al.
BMC Genomics|February 24, 2025
Lineage-specific variation in frequency and hotspots of recombination in invasive Escherichia coliKathryn R Piper, Stephanie S R Souza, Odion O Ikhimiukor, et al.
Journal of Clinical Microbiology|February 24, 2025
A novel framework for the automated characterization of Gram-stained blood culture slides using a large-scale vision transformerJack McMahon, Naofumi Tomita, Elizabeth S Tatishev, et al.
ASM Case Reports|July 8, 2026
Beyond the bladder: case series of Mycobacterium bovis bacillus Calmette-Guérin infections following intravesical instillationAdrienne A Workman, Ourania Parra, Nicole A Loeven, et al.
The Journal of Biological Chemistry|July 9, 2015
Expression of V3 Versican by Rat Arterial Smooth Muscle Cells Promotes Differentiated and Anti-inflammatory PhenotypesInkyung Kang, Jeremy L Barth, Erin P Sproul, et al.
Cancer Biology & Therapy|June 16, 2023
Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancerCha Len Lee, Mattia Cremona, Angela Farrelly, et al.
Pageof 8